Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Novo Holdings

Profile, fund size and leaders

Parent Novo Nordisk FoundationHQ Hellerup, DenmarkFounded 1999

Novo Holdings is the corporate venture arm of Novo Nordisk Foundation. It was founded in 1999 and is based in Hellerup, Denmark. It invests from pre-seed to late stage. Sectors it names: biotech and life sciences, medical devices, healthcare and digital health, climate and energy.

AUM or capital under managementS3
DKK 694bn
Companies backedS3
171

Every figure links to its source

Snapshot

Investment stage: Pre-seed to Late stage
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangePre-seed to Late stage
SectorsBiotech and life sciences, Medical devices, Healthcare and digital health, Climate and energy
GeographyNorth America, Europe, Asia
OfficesHellerup, Denmark, San Francisco, United States, Boston, United States, London, United Kingdom, Singapore, Shanghai, China, Mumbai, India

Sources: S1 Novo Holdings About; S3 Novo Holdings Investments.

Graphic 1 of 2

Investment stage: Pre-seed to Late stage

Sources: S1 Novo Holdings About; S3 Novo Holdings Investments.

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeDKK 694bnAUM or capital under managementStated by the firm or its parentS3
Companies backed171companiesStated by the firmS3

Sources: S3 Novo Holdings Investments.

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S3 Novo Holdings Investments.

Download:Report a correction

Where it invests and who leads it

LeadersS6S8S7

Novo Holdings on LinkedIn

Key facts

FactValueStatusSource
Parent companyNovo Nordisk FoundationSingle sourceS2
Parent industryOtherSingle sourceS2
Founded1999Single sourceS2
HeadquartersHellerup, DenmarkSingle sourceS11
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS2
Headline sizeDKK 694bn (AUM or capital under management)Single sourceS3
Companies backed171Single sourceS3
People on the team page235Single sourceS12
StagesPre-seed, Seed, Series A, Series B, Series C+, Growth, Late stage (inferred from announced rounds)EstimateS1

For founders

ItemWhat the firm saysSource
StagesPre-seed, Seed, Series A, Series B, Series C+, Growth, Late stage. Inferred from announced rounds; the firm does not state a range.S1
Leads roundsYesS4

Notable outcomes

IPOs and acquisitions of portfolio companies. Price shown only where published.

CompanyTypeYearAcquirer or exchangeSource
Myricx BioAcquisition2026NovartisS14
MapLight TherapeuticsIPO2025S4
Blueprint MedicinesAcquisition2025S4
MerusAcquisition2025S4

Fund vehicles

VehicleSizeYearSource
Venture Investments 2025 annual commitmentsUSD 749M2025S4
Seed Investments deployed 2025DKK 1.2bn2025S5

Investments by year

YearTotalSource
202033S13
202525S4

Recent rounds

DateCompanyRoundAmountLed by the firmSource
2026-05-04Windward BioNot statedUSD 165MNoS14
2026-04-28Coultreon BiopharmaSeries AUSD 125MYesS14

History

  1. Novo Holdings incorporated to manage the assets of the Novo Nordisk Foundation.S2
  2. Kasim Kutay becomes CEO on 1 September 2016.S6
  3. Scott Beardsley appointed Head of Novo Ventures.S13

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Novo Holdings AboutFirm
  2. S2Novo Holdings Facts and FiguresFirm
  3. S3Novo Holdings InvestmentsFirm
  4. S4Novo Holdings 2025 Venture Investments annual review release (12 Jan 2026)Firm
  5. S5Novo Holdings Seed InvestmentsFirm
  6. S6Novo Holdings Kasim Kutay profileFirm
  7. S7Novo Holdings Soren Moller profileFirm
  8. S8Novo Holdings Scott A. Beardsley profileFirm
  9. S9Scott Beardsley LinkedIn profile headlineThird-party report
  10. S10Novo Holdings Venture InvestmentsFirm
  11. S11Novo Holdings Leadership and addressesFirm
  12. S12Novo Holdings People and CareersFirm
  13. S13Novo Ventures business update on 2020Firm
  14. S14Novo Holdings news page (Coultreon Biopharma and Windward Bio items)Firm
  15. S15Novo Holdings linkedin company pageFirm

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Novo Holdings or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.